DONATE

Search Results for:

IBEC participates in the first Workplace Travel Plan launched by the Barcelona Science Park to promote more sustainable mobility

The University of Barcelona Science Park (PCB-UB) has launched its first Workplace Travel Plan (PDE), a joint initiative by the Institute for Bioengineering of Catalonia (IBEC), the Institute for Research in Biomedicine (IRB Barcelona), Biocat, the Scientific and Technological Centers of the UB (CCiTUB), and the PCB itself, aimed at improving commuting mobility and reducing the environmental impact of daily travel.

Barcelona hosts the fourth edition of the EMBL-IBEC Conference

The fourth EMBL-IBEC Conference, organised by the Institute for Bioengineering of Catalonia (IBEC) and the European Molecular Biology Laboratory (EMBL), focused on disease modelling, developmental biology, and regenerative medicine. The event brought around 130 international bioengineering experts together at the PRBB in Barcelona this week.

IBEC Seminar: Dr. Mykhailo Batiuk

Glia, Schizophrenia, and Trauma at Cellular Resolution Dr. Mykhailo Batiuk,  École Polytechnique Fédérale de Lausanne. The complexity of the brain in both health and pathology stems from its immense cellular … Read more

IBEC welcomes a new international cohort of doctoral students in collaboration with hospitals and centres of excellence

The Institute for Bioengineering of Catalonia (IBEC) is pleased to welcome new international students to its PhD programme. This initiative offers excellent training and research opportunities in bioengineering, as well as strong collaboration with leading hospitals and institutions.

IBEC showcases its leadership in biomedical innovation at MWC26 with three disruptive projects

Last week, Barcelona played host to MWC26, the world’s premier technology and connectivity event. The Institute for Bioengineering of Catalonia was in attendance, showcasing some of its spin-offs and state-of-the-art biomedical technologies, including: Nanobots Therapeutics, Lumiris Spectral Solutions, and Drug4Sight.